IHS Holding Limited (IHS) Dividend History

Company News

• US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'

  U.S. stock futures were flat on Tuesday as investors remained cautious ahead of the FOMC meeting. Analysts say the only certainty is that 'things will remain uncertain for the time being'.

  Benzinga

  Featured Companies: BKKT BON GES GETY HQY HROW HROWL HROWM QQQ SGMO SPY STN
• The Latest Analyst Ratings For IHS Holding

  Analysts' ratings for IHS Holding (NYSE:IHS) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 2 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.62, a high estimate of $15.00, and a low estimate of $6.00. A 21.33% drop is evident in the current average compared to the previous average price target of $13.50. Analyzing Analyst Ratings: A Detailed Breakdown In examining recent analyst actions, we gain insights into how financial experts perceive IHS Holding. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Colby Synesael TD Cowen Lowers Buy $13.00 $15.00 Maurice Patrick Barclays Lowers Overweight $6.00 $8.00 Gregory Williams TD Cowen Lowers Outperform $15.00 $19.00 Eric Luebchow Wells Fargo Lowers Overweight $8.50 $12.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to IHS Holding. This offers insight into analysts' perspectives on ...Full story available on Benzinga.com

  Benzinga
• Zacks Industry Outlook Highlights IHS Holding and DZS

  IHS Holding and DZS have been highlighted in this Industry Outlook article.

  Zacks Investment Research
• 2 Communication Stocks Likely to Stand Firm Amid Industry Gloom

  The infrastructure upgrade for digital transformation, fiber densification and 5G rollout should help the Zacks Communication - Infrastructure industry thrive despite near-term headwinds. IHS and DZSI are likely to benefit from the continued transition to cloud networks.

  Zacks Investment Research
• Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

  Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share. Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Stoke Therapeutics, Inc. (NASDAQ: STOK) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. C3is Inc. (NASDAQ: CISS) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million. Mesoblast Limited (NASDAQ: MESO) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease. Praxis Precision Medicines Inc (NASDAQ: PRAX) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. Nuvation Bio Inc (NYSE: NUVB) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI. Viking Therapeutics ...

  Benzinga

  Featured Companies: AKBA CDLX CGC CHEK CISS DERM DNUT EQ GLUE GTI GWAV IPDN IVVD MKC MRNO NGVC NOVA NUVB PRAX RDDT RH STOK STX SXTP TIVC TSLA VKTX WPRT